Lv1
10 积分 2023-02-10 加入
Synthetic lethal strategies for the development of cancer therapeutics
4天前
已完结
DNA Methyltransferase 3A: A Significant Target for the Discovery of Inhibitors as Potent Anticancer Drugs
1个月前
已完结
KDM1A, a potent and selective target, for the treatment of DNMT3A-deficient non-small cell lung cancer
1个月前
已完结
Targeted protein degradation: from mechanisms to clinic
4个月前
已完结
Discovery of 2-Aryl-4-aminoquinazolin-Based LSD1 Inhibitors to Activate Immune Response in Gastric Cancer
5个月前
已完结
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
1年前
已完结
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics
1年前
已完结
An MDM2 degrader for treatment of acute leukemias
1年前
已完结
Fingolimod attenuates ovalbumin‐induced airway inflammation via inhibiting MAPK/ERK signaling in mice
1年前
已完结
An Update of Lysine Specific Demethylase 1 Inhibitor: A Patent Review (2016-2020)
2年前
已完结
皖公网安备34019202002308
